The selective functionalizations of container molecules are important tasks to expand its research fields. In case of covalent-bonded container molecules based on resorcin[4]-arene their functionalization methods are quite limited compared to those for molecular capsules or calixarenes.
, which are mostly functionalized on their tropical regions.
The homogeneous four-feet functionalizations of C 4v resorcin[4]arene gave various functional container molecules such as monolayer of carceplex, 7b metal-coordinated oligomers, 7c and water soluble molecular capsules. 7d Especially the selective monofunctionalization methods on a foot 8a,b of resorcin [4] arene gave the important intermediates for the new kinds of self-assemblies such as π-π stacked oligomers, 8b,9a star-shaped supramolecular polymer, 9b and selfsorting hexameric capsules.
9c Here are reported carceplexes 6 and 7 having a p-bromophenyl foot which can be used as a platform for the molecular engineering of carceplexes.
The key compound 1, p-bromophenyl tetramethyloctol, was obtained by the hetero condensation among 2-methylresorcinol, 4-bromobenzaldehyde, and octanal in about 40% yield.
8b Tetramethylcavitand 2 was obtained in 33% yield by the 4-fold intramolecular cyclization of octol 1 using CH 2 BrCl and K 2 CO 3 . Tetramethylcavitand 2 was converted to p-bromophenyl tetrakis(bromomethyl)cavitand 3 by NBS/ AIBN in 42% yield.
The shell-closing reaction between p-bromophenyl tetrakis-(bromomethyl)cavitand 3 and tetrakis(thiomethyl)cavitand 4 in a mixture of methyl ethyl ketone (MEK) or N,N-dimethylformamide (DMF) and Rb 2 CO 3 gave MEK@carcerand 5 (carceplex 6) or DMF@carcerand 5 (carceplex 7) in 56% and 25% yield, respectively. The structures of MEK@-carcerand 5 and DMF@carcerand 5 were characterized with Scheme 1. Synthesis of p-Bromophenylcavitand 3 (R=Heptyl).
Scheme 2. Synthesis of carceplexes 6 and 7 (R=Heptyl) having a functionalized foot.
MALDI TOF Mass and
1 H NMR spectrometry. Carceplexes 6 and 7 have a US football-shaped cavity whose dimensions are roughly 11 Å × 6 Å. The complexed linear guest tends to orient through the long axis of cavity in which guest's terminal hydrogen nests deep into the two poles of host where the magnetic shielding effects from the four benzene units are overlapped. Table 1 shows the chemical shift changes of hydrogens of incarcerated guests. MEK is more linear compared to DMF, so the terminal methyls of MEK nest proximal to the poles to give the two largest Δδ of 3.99 and 4.07. The larger Δδ of H c , 4.07, than that of H a , 3.99, is also due to their steric effect difference.
Such intrinsic properties of monomeric carceplexes have been extensively studied, 1 but the studies on the cooperative multi-properties of dimer, oligomer, network, micelle, or membrane of container molecules are yet left to be explored. Figure 1 shows a prototypical biscarceplex 8, two different carceplexes connected through a oligophenylene foot, which can be obtained from carceplexes 6, 7, or their analogues. The interactions between two incarcerated guests through oligophenylene bridge would change the electric or magnetic properties and the redox potentials, which could influence the relative orientational preferences or the stabilities of incarcerated guests. Such an interesting study will open a new era of supramolecular chemistry.
Experimental Section
Materials and General Procedures. All chemicals were reagent grades and directly used unless otherwise specified. All anhydrous reactions were conducted under an argon atmosphere. Melting points were determined using an Electrothermal IA9100 apparatus without calibration. MALDI-TOF Mass spectra were run on a Voyager-DE TM STR Biospectrometry at National Center for Inter University Research Facilities (Seoul National University). The 1 H NMR spectra were recorded on a Brucker Avance (400 MHz) spectrometer in CDCl 3 unless stated otherwise. Gravity column chromatography was performed on silica gel 60 (E. Merck, 70-230 mash ASTM).
p-Bromophenyl Tetramethylcavitand 2. A mixture of octol 1 (10 g, 10 mmol), CH 2 BrCl (3.4 mL, 50 mmol), K 2 CO 3 (8.5 g), and DMF (50 mL) was stirred at 50 o C overnight. The mixture was partitioned between 3 N HCl (100 mL) and CH 2 Cl 2 (50 mL), and the organic phase was separated, washed with 3 N HCl, brine, and then dried over MgSO 4 . The solvent was evaporated and the residue was purified by silica gel chromatography using a mixture of EtOAc/Hexane (1:11). The best fractions were collected, concentrated, and the residue was recrystallized in a mixture of CH 3 CN/CH 2 Cl 2 to give a product (3.5 C NMR (100 MHz, CDCl 3 ) δ 9.4, 9.5, 13.2, 13. 3, 21.8, 21.9, 27.0, 27.3, 28.5, 28.7, 28.8, 29.0, 29.3, 30.9, 31.1, 36.1, 36.2, 41.3, 97.7, 116.8, 119.3, 119.7, 122.8, 123.3, 130.2, 135.8, 137.0, 137.2, 139.0, 152.3, 153.1. p-Bromophenyl Tetrakis(bromomethyl)cavitand 3. A mixture of cavitand 2 (2 g, 2 mmol), NBS (2 g, 11 mmol), AIBN (2 mg), and CCl 4 (50 mL) was refluxed for 5 hrs. The mixture was cooled to rt and the solvent was evaporated. The residue was partitioned between water (100 mL) and CH 2 Cl 2 (50 mL), and the organic phase was separated, washed with brine, and then dried over MgSO 4 . The solvent was evaporated and the residue was purified by silica gel chromatography using a 2:1 mixture of Hexane/CH 2 Cl 2 . The best fractions were collected, concentrated, and the residue was recrystallized in a mixture of CH 2 Cl 2 /EtOH to give a product (1.08 1, 22.6, 22.7, 22.9, 27.8, 28.1, 29.3, 29.5, 29.8, 30.2, 31.8, 31.9, 36.9, 41.9, 99.2, 121.0, 123.9, 124.5, 125.0, 130.9, 131.4, 136.8, 137.9, 138.3, 138.8, 153.4, 154.3. Tetrakis(thiomethyl)cavitand 4. A mixture of tetrakis-(bromomethyl)cavitand 10 (1.0 g, 0.93 mmol), thiourea (566 mg, 7.4 mmol), and DMF (5 mL) was stirred for 3 hrs at 60 5, 18.5, 21.3, 32.5, 37.0, 100.3, 119.7, 127.6, 138.4, 153.5 .
MEK@p-Bromophenyl Carcerand 5 (Carceplex 6). A solution of p-bromophenyl tetrakis(bromomethyl)cavitand 3 (300 mg, 0.22 mmol), tetrakis(thiomethyl)cavitand 4 (196 mg, 0.22 mmol), and MEK (100 mL) was added for 12 hrs to a refluxing mixture of Rb 2 CO 3 (1.02 g) and MEK (100 mL) in a 500 mL Round-bottom flask. After additional 12 hrs refluxing, the solvent was evaporated and the residue was partitioned between water and CH 2 Cl 2 . The organic phase was separated and washed with brine, and then dried over MgSO 4 . The solvent was evaporated and the residue was purified by silica gel chromatography using a 1:3 mixture of hexane/CH 2 Cl 2 . The best fractions were collected, concentrated, and the residue was recrystallized in a mixture of CH 3 Cl/CH 3 CN to give a product (White powder, 245 DMF@p-Bromophenyl Carcerand 5 (Carceplex 7). A solution of p-bromophenyl tetrakis(bromomethyl)cavitand 3 (300 mg, 0.22 mmol), tetrakis(thiomethyl)cavitand 4 (196 mg, 0.22 mmol), and DMF (100 mL) was added for 12 hrs to a mixture of Rb 2 CO 3 (1.02 g) and DMF (100 mL) at 80 o C in a 500 mL Round-bottom flask. After additional 12 hrs stirring at 80 o C, the reaction mixture was cooled to room temperature and then partitioned between 3 N HCl (150 mL) and CH 2 CH 2 (150 mL). The aqueous phase was extracted with 50 mL of CH 2 CH 2 and the combined organic phase was washed with 100 mL of 3 N HCl. The organic phase was separated and washed with brine, and then dried over MgSO 4 . The solvent was evaporated and the residue was purified by silica gel chromatography using a 1:3 mixture of hexane/CH 2 Cl 2 . The best fractions were collected, concentrated, and the residue was recrystallized in a mixture of CH 3 Cl/CH 3 CN to give a product (White powder, 112 
